Medtronic said this month it opened a new headquarters for its non-intensive diabetes therapy business unit in Plymouth, Minn.
The newly opened facility will act as the global headquarters for the company’s NDT biz, as well as housing product development, research and development, marketing and operations, Fridley, Minn.-based Medtronic said.
“Having our own space means we’ve firmly committed to Medtronic being a leader in type 2 diabetes.
